Compare uniQure N.V. Ordinary Shares (QURE) vs W.R. Berkley Corporation Common Stock (WRB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs W.R. Berkley Corporation Common Stock — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while W.R. Berkley Corporation Common Stock trades at $74.25 (market cap $27.30B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 18.4× uniQure N.V. Ordinary Shares's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| QURE | WRB | |
|---|---|---|
Market Cap | $1.48B | $27.30B |
Volume | 2,488,780 | 2,293,079 |
Sector | Health | Financials |
52-Week High | $70.59 | $78.10 |
52-Week Low | $9.03 | $63.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $728.62M | $27.54B |
Dividend Yield | — | 0.54% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About W.R. Berkley Corporation Common Stock
W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →
